ZA200301869B - Novel crystals of N-hydroxy-2 (S)-methyl-5-ethoxymethoxy-4 (S)-[N-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient. - Google Patents

Novel crystals of N-hydroxy-2 (S)-methyl-5-ethoxymethoxy-4 (S)-[N-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient. Download PDF

Info

Publication number: ZA200301869B
Authority: ZA; South Africa
Prior art keywords: type; crystal; ethoxymethoxy; phenoxyphenylcarbonyl; pentanamide
Prior art date: 2000-09-08

Application number

ZA200301869A

Other languages

English (en)

Inventor

Shigehiro Okuyama

Masaki Okamoto

Original Assignee

Ono Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-08

Filing date

2003-03-06

Publication date

2004-06-25

2003-03-06 Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co

2004-06-25 Publication of ZA200301869B publication Critical patent/ZA200301869B/en

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C235/50—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Vascular Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Pulmonology (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

ZA200301869A 2000-09-08 2003-03-06 Novel crystals of N-hydroxy-2 (S)-methyl-5-ethoxymethoxy-4 (S)-[N-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient. ZA200301869B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP2000273445		2000-09-08

Publications (1)

Publication Number	Publication Date
ZA200301869B true ZA200301869B (en)	2004-06-25

Family

ID=18759384

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200301869A ZA200301869B (en)	2000-09-08	2003-03-06	Novel crystals of N-hydroxy-2 (S)-methyl-5-ethoxymethoxy-4 (S)-[N-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient.

Country Status (16)

Country	Link
US (1)	US20040152785A1 (pl)
EP (1)	EP1316547A4 (pl)
KR (1)	KR20030059125A (pl)
CN (1)	CN1473148A (pl)
AU (1)	AU2001284477A1 (pl)
BR (1)	BR0113760A (pl)
CA (1)	CA2419744A1 (pl)
CZ (1)	CZ2003636A3 (pl)
HU (1)	HUP0302928A3 (pl)
IL (1)	IL154625A0 (pl)
MX (1)	MXPA03001985A (pl)
NO (1)	NO20031030L (pl)
PL (1)	PL361702A1 (pl)
RU (1)	RU2003106391A (pl)
WO (1)	WO2002020467A1 (pl)
ZA (1)	ZA200301869B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0100761D0 (en)	2001-01-11	2001-02-21	Biocompatibles Ltd	Drug delivery from stents
KR101013932B1 (ko) *	2003-10-21	2011-02-14	워너-램버트 캄파니 엘엘씨	Ｎ-[(ｒ)-2,3-디히드록시-프로폭시]-3,4-디플루오로-2-(2-플루오로-4-요오도페닐아미노)-벤자미드 다형체 형태
US7713541B1 (en)	2006-11-21	2010-05-11	Abbott Cardiovascular Systems Inc.	Zwitterionic terpolymers, method of making and use on medical devices

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1024134A4 (en) *	1997-10-09	2003-05-14	Ono Pharmaceutical Co	DERIVATIVES OF AMINOBUTANIC ACID

2001
- 2001-09-07 CZ CZ2003636A patent/CZ2003636A3/cs unknown
- 2001-09-07 PL PL01361702A patent/PL361702A1/pl unknown
- 2001-09-07 MX MXPA03001985A patent/MXPA03001985A/es not_active Application Discontinuation
- 2001-09-07 CN CNA018185525A patent/CN1473148A/zh active Pending
- 2001-09-07 WO PCT/JP2001/007775 patent/WO2002020467A1/ja not_active Ceased
- 2001-09-07 CA CA002419744A patent/CA2419744A1/en not_active Abandoned
- 2001-09-07 BR BR0113760-3A patent/BR0113760A/pt not_active Application Discontinuation
- 2001-09-07 EP EP01963509A patent/EP1316547A4/en not_active Withdrawn
- 2001-09-07 HU HU0302928A patent/HUP0302928A3/hu unknown
- 2001-09-07 IL IL15462501A patent/IL154625A0/xx unknown
- 2001-09-07 KR KR10-2003-7003266A patent/KR20030059125A/ko not_active Withdrawn
- 2001-09-07 US US10/362,290 patent/US20040152785A1/en not_active Abandoned
- 2001-09-07 RU RU2003106391/04A patent/RU2003106391A/ru not_active Application Discontinuation
- 2001-09-07 AU AU2001284477A patent/AU2001284477A1/en not_active Abandoned
2003
- 2003-03-05 NO NO20031030A patent/NO20031030L/no not_active Application Discontinuation
- 2003-03-06 ZA ZA200301869A patent/ZA200301869B/en unknown

Also Published As

Publication number	Publication date
NO20031030L (no)	2003-05-08
IL154625A0 (en)	2003-09-17
BR0113760A (pt)	2003-07-15
MXPA03001985A (es)	2003-09-05
KR20030059125A (ko)	2003-07-07
EP1316547A4 (en)	2005-10-12
PL361702A1 (pl)	2004-10-04
WO2002020467A1 (fr)	2002-03-14
RU2003106391A (ru)	2004-07-27
CN1473148A (zh)	2004-02-04
NO20031030D0 (no)	2003-03-05
AU2001284477A1 (en)	2002-03-22
EP1316547A1 (en)	2003-06-04
HUP0302928A3 (en)	2005-03-29
CZ2003636A3 (cs)	2003-08-13
HUP0302928A2 (hu)	2003-12-29
US20040152785A1 (en)	2004-08-05
CA2419744A1 (en)	2003-02-26

Publication	Publication Date	Title
EP2991999B1 (en)	2019-05-08	Dapagliflozin lactose co-crystal
CN106661015B (zh)	2020-04-24	达沙替尼盐
JP2022545195A (ja)	2022-10-26	塩
EP3080141A1 (en)	2016-10-19	Solid form of abiraterone acetate
CA3094167A1 (en)	2019-09-26	Crystalline forms and methods of producing crystalline forms of a compound
EP1908757A1 (en)	2008-04-09	Choline salt crystal of azulene compound
EP1832582A1 (en)	2007-09-12	Novel raloxifene malonic acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these
JP2005507899A (ja)	2005-03-24	カルベジロールの疑似多形形態
EP1316547A1 (en)	2003-06-04	Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)- n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient
EP3177591A1 (en)	2017-06-14	Multi-component crystals of vismodegib and selected co-crystal formers or solvents
US20080234286A1 (en)	2008-09-25	Stable amorphous imatinib mesylate and production process therefor
KR102097250B1 (ko)	2020-04-03	신규한 이프라글리플로진의 결정형, 이의 제조방법 또는 용도
EP2729460B1 (en)	2016-01-13	Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride
US20040023998A1 (en)	2004-02-05	Novel crystals of 1,3,4-oxadiazole derivatives, process for producing the crystals and medicines containing the same as the active ingredient
AU2022412842B2 (en)	2025-11-27	Novel acid addition salt and crystalline form of (2r,3s)-2-(3-(4,5-dichloro-1h-benzo[d]imidazol-1-yl)propyl)piperidin-3-ol
EP4509499A1 (en)	2025-02-19	Polymorph of 7,8-dihydroxyflavone, and preparation method therefor
EP3368527B1 (en)	2021-04-28	Palbociclib tosylate
EA020944B1 (ru)	2015-02-27	Кристаллическая форма i соли розувастатина цинка
EP1813602A1 (en)	2007-08-01	Crystal of two-ring heterocyclic sulfonamide compound
CN101115706A (zh)	2008-01-30	制备普伐他汀钠的方法
WO2026074067A1 (en)	2026-04-09	Solid forms of a gamma-secretase modulator
JPWO2002020467A1 (ja)	2003-10-21	Ｎ−ヒドロキシ−２（ｓ）−メチル−５−エトキシメトキシ−４（ｓ）−［ｎ−（４−フェノキシフェニルカルボニル）アミノ］ペンタンアミドの新規結晶、その製造方法およびそれを有効成分として含有する薬剤
CN102219752B (zh)	2013-04-10	一种1-(2,6-二氟苄基)-1h-1,2,3-三唑-4-甲酰胺的晶型d
WO2003042161A1 (en)	2003-05-22	Venlafaxine hydrochloride polymorphs
HK1192546B (en)	2016-11-04	Crystalline solvates of 6-(piperidin-4-yloxy)-2h-isoquinolin-1-one hydrochloride